The global Amnestic Disorders Therapeutics Market is currently at a critical juncture. As 2025 progresses, the industry is transitioning from purely symptomatic relief to disease-modifying interventions. Driven by an aging global population and breakthroughs in neuro-regenerative medicine, the market for treating amnesia—whether caused by trauma, stroke, or neurodegeneration—is expand... https://in.linkedin.com/company/data-bridge-market-research